Bioavailability of Nanoemulsified Conjugated Linoleic Acid for an Antiobesity Effect

Overview

Journal Int J Nanomedicine

Publisher Dove Medical Press

Specialty Biotechnology

Date 2013 Feb 23

PMID 23429301

Citations 4

Authors

Dongyeop Kim

Jin-Hong Park

Dae-Jun Kweon

Gi Dong Han

Affiliations

Soon will be listed here.

Abstract

Background: The aim of this study was to enhance the bioavailability of conjugated linoleic acid (CLA), which has low water solubility, using nanoemulsion technology and to evaluate the effects of its improved bioavailability as an antiobesity agent.

Methods: The antiobesity effect of nanoemulsified water-soluble conjugated linoleic acid (N-CLA) was evaluated using in vitro and in vivo studies. Differentiated 3T3-L1 adipocytes were treated with CLA and N-CLA to assess their lipolytic effect. Further, to confirm the antiobesity effect of N-CLA, male Sprague-Dawley rats were randomly separated into four groups, ie, a group fed a normal diet, a group fed a high-fat diet (obesity rat model), a CLA-treated group, and an N-CLA-treated group.

Results: N-CLA showed a greater lipolytic effect on differentiated 3T3-L1 adipocytes compared with normal CLA. N-CLA enhanced the release of glycerol from triglycerides, which accumulated in differentiated 3T3-L1 adipocytes. Further, N-CLA enhanced leptin secretion to an extent similar to that of orlistat, an antiobesity agent. In an animal obesity model fed a high-fat diet, N-CLA attenuated accumulation of triglycerides, total cholesterol, and low-density lipoprotein cholesterol in serum, and also significantly decreased the volume of triglycerides and cholesterol in liver tissue.

Conclusion: These results indicate that N-CLA has a greater antiobesity effect than CLA as a result of its improved bioavailability.

Citing Articles

Beneficial Effects of Plant Oils Supplementation on Multiple Sclerosis: A Comprehensive Review of Clinical and Experimental Studies.

Al-Naqeb G, Kalmpourtzidou A, De Giuseppe R, Cena H Nutrients. 2023; 15(22).

PMID: 38004221 PMC: 10674509. DOI: 10.3390/nu15224827.

Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue.

Dias S, Paredes S, Ribeiro L Int J Endocrinol. 2018; 2018:2637418.

PMID: 29593789 PMC: 5822899. DOI: 10.1155/2018/2637418.

Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.

Binyamin O, Larush L, Frid K, Keller G, Friedman-Levi Y, Ovadia H Int J Nanomedicine. 2015; 10:7165-74.

PMID: 26648720 PMC: 4664546. DOI: 10.2147/IJN.S92704.

In vivo characterization of the biodistribution profile of amphipol A8-35.

Fernandez A, Le Bon C, Baumlin N, Giusti F, Cremel G, Popot J J Membr Biol. 2014; 247(9-10):1043-51.

PMID: 24898094 PMC: 4198491. DOI: 10.1007/s00232-014-9682-8.

References

Perez-Matute P, Marti A, Martinez J, Fernandez-Otero M, Stanhope K, Havel P . Conjugated linoleic acid inhibits glucose metabolism, leptin and adiponectin secretion in primary cultured rat adipocytes. Mol Cell Endocrinol. 2007; 268(1-2):50-8. DOI: 10.1016/j.mce.2007.01.013. View

Munday J, Thompson K, James K . Dietary conjugated linoleic acids promote fatty streak formation in the C57BL/6 mouse atherosclerosis model. Br J Nutr. 1999; 81(3):251-5. DOI: 10.1017/s0007114599000458. View

Padwal R, Majumdar S . Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet. 2007; 369(9555):71-7. DOI: 10.1016/S0140-6736(07)60033-6. View

Blankson H, Stakkestad J, Fagertun H, Thom E, Wadstein J, Gudmundsen O . Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr. 2000; 130(12):2943-8. DOI: 10.1093/jn/130.12.2943. View

Fan J, Kim H, Han G . Induction of apoptosis by L-carnitine through regulation of two main pathways in Hepa1c1c 7 cells. Amino Acids. 2008; 36(2):365-72. DOI: 10.1007/s00726-008-0093-y. View

DeLany J, Blohm F, Truett A, Scimeca J, West D . Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake. Am J Physiol. 1999; 276(4):R1172-9. DOI: 10.1152/ajpregu.1999.276.4.R1172. View

Guerciolini R . Mode of action of orlistat. Int J Obes Relat Metab Disord. 1997; 21 Suppl 3:S12-23. View

Kim J, Pan J, Park H, Yoon H, Kwon O, Kim T . Functional comparison of esterified and free forms of conjugated linoleic acid in high-fat-diet-induced obese C57BL/6J mice. J Agric Food Chem. 2010; 58(21):11441-7. DOI: 10.1021/jf102164j. View

Yu H, Huang Q . Investigation of the absorption mechanism of solubilized curcumin using Caco-2 cell monolayers. J Agric Food Chem. 2011; 59(17):9120-6. DOI: 10.1021/jf201451m. View

10.

Nicolosi R, Rogers E, Kritchevsky D, Scimeca J, Huth P . Dietary conjugated linoleic acid reduces plasma lipoproteins and early aortic atherosclerosis in hypercholesterolemic hamsters. Artery. 1997; 22(5):266-77. View

11.

Kennedy A, Martinez K, Schmidt S, Mandrup S, LaPoint K, McIntosh M . Antiobesity mechanisms of action of conjugated linoleic acid. J Nutr Biochem. 2009; 21(3):171-9. PMC: 2826589. DOI: 10.1016/j.jnutbio.2009.08.003. View

12.

West D, DeLany J, Camet P, Blohm F, Truett A, Scimeca J . Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am J Physiol. 1998; 275(3):R667-72. DOI: 10.1152/ajpregu.1998.275.3.R667. View

13.

Sharma R, Euden S, Platton S, Cooke D, Shafayat A, Hewitt H . Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res. 2004; 10(20):6847-54. DOI: 10.1158/1078-0432.CCR-04-0744. View

14.

Kang K, Pariza M . trans-10,cis-12-Conjugated linoleic acid reduces leptin secretion from 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2001; 287(2):377-82. DOI: 10.1006/bbrc.2001.5603. View

15.

Silveira M, Carraro R, Monereo S, Tebar J . Conjugated linoleic acid (CLA) and obesity. Public Health Nutr. 2007; 10(10A):1181-6. DOI: 10.1017/S1368980007000687. View

16.

Ide T . Interaction of fish oil and conjugated linoleic acid in affecting hepatic activity of lipogenic enzymes and gene expression in liver and adipose tissue. Diabetes. 2005; 54(2):412-23. DOI: 10.2337/diabetes.54.2.412. View

17.

Dagon Y, Avraham Y, Berry E . AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2alpha in adipocytes. Biochem Biophys Res Commun. 2005; 340(1):43-7. DOI: 10.1016/j.bbrc.2005.11.159. View

18.

Satory D, Smith S . Conjugated linoleic acid inhibits proliferation but stimulates lipid filling of murine 3T3-L1 preadipocytes. J Nutr. 1999; 129(1):92-7. DOI: 10.1093/jn/129.1.92. View

19.

Wahle K, Heys S, Rotondo D . Conjugated linoleic acids: are they beneficial or detrimental to health?. Prog Lipid Res. 2004; 43(6):553-87. DOI: 10.1016/j.plipres.2004.08.002. View

20.

Brown J, Boysen M, Jensen S, Morrison R, Storkson J, Lea-Currie R . Isomer-specific regulation of metabolism and PPARgamma signaling by CLA in human preadipocytes. J Lipid Res. 2003; 44(7):1287-300. PMC: 1351019. DOI: 10.1194/jlr.M300001-JLR200. View